Skip to main content

Health condition · Clinically reviewed

Psoriatic arthritis, early recognition prevents joint damage.

Inflammatory arthritis in psoriasis patients. Early treatment prevents structural joint damage — GRAPPA-aligned care with biologics has transformed outcomes.

Jump to treatment See red flags
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Every claim is checked against NICE, GRAPPA, EULAR or peer-reviewed sources you can see at the end.

  • 03

    Current for 2026

    Reflects current UK guidance on early biologic therapy and modern GRAPPA-aligned care.

Key facts

Psoriatic arthritis at a glance.

The essentials, in plain English — what PsA is, how it is recognised, and how it is treated in the UK today.

  • Definition

    Inflammatory arthritis occurring in people with psoriasis or psoriatic nail disease — an immune-mediated joint and entheseal disease.

  • How common

    Affects up to 30% of people with psoriasis — often develops years after skin disease, but can precede it.

  • Five patterns

    Oligoarticular, polyarticular, DIP-predominant, arthritis mutilans and spondylitis — patterns often overlap and evolve.

  • Nails and dactylitis

    Nail pitting, onycholysis and sausage-digit dactylitis are diagnostic clues that separate PsA from other arthritides.

  • GRAPPA + EULAR

    GRAPPA and EULAR treatment recommendations guide the choice of DMARD, biologic or targeted synthetic therapy.

  • Biologics transform

    Anti-TNF, IL-17 and IL-23 biologics have transformed outcomes — remission and low disease activity are realistic goals.

Why this guide matters

Early recognition changes everything.

The gap between joint symptoms and diagnosis is where damage happens — screening psoriasis patients and starting therapy early protects joints for life.

  • A treatable window

    Recognising PsA within the first months of joint symptoms is the treatment window — early therapy prevents erosive damage.

  • Modern medicines change lives

    Anti-TNF, IL-17 and IL-23 biologics mean remission is a realistic goal for most people today.

  • Whole-person care

    Alongside joints, skin, eyes, cardiovascular risk and mood all deserve active management.

How the diagnosis is made

From first swollen joint to a clear plan.

The steps a UK GP and rheumatology team will normally follow, in order — so you know what to expect and why.

  1. 01

    Recognising

    PEST or PsAID screening in psoriasis

    Every psoriasis patient should be screened annually with the PEST questionnaire — a positive score triggers rheumatology review.

  2. 02

    Recognising

    Bloods (CRP, RF, anti-CCP)

    CRP shows inflammation; rheumatoid factor and anti-CCP are usually negative — helping distinguish PsA from RA.

  3. 03

    Recognising

    Hand and foot X-ray

    Looks for erosive change, DIP involvement, pencil-in-cup deformity and periostitis — often normal early on.

  4. 04

    Confirming

    Musculoskeletal ultrasound / MRI

    Detects synovitis, enthesitis, tenosynovitis and early erosions before X-ray changes are visible.

  5. 05

    Confirming

    Nail examination

    Nail pitting, onycholysis and subungual hyperkeratosis are strongly associated with DIP disease.

  6. 06

    Confirming

    Rheumatology referral

    NICE recommends prompt rheumatology review for suspected inflammatory arthritis — do not wait for bloods.

  7. 07

    Baseline

    Baseline biologic-screening bloods

    TB screening, hepatitis serology, HIV and baseline immunoglobulins — required before starting a biologic.

Typical timeline: 4–8 weeks from first appointment to starting a DMARD or biologic.

Symptoms

What psoriatic arthritis actually feels like.

The combination is more telling than any single symptom — peripheral arthritis with dactylitis, enthesitis, nail changes or spondylitis in someone with psoriasis.

  • Peripheral arthritis

    Asymmetric or symmetric joint swelling — knees, ankles, wrists, fingers and toes are typical.

  • Dactylitis (sausage digit)

    Uniform swelling of a whole finger or toe — a hallmark feature and marker of more severe disease.

  • Enthesitis

    Pain and tenderness where tendons or ligaments attach to bone — heels, Achilles and plantar fascia are classic.

  • Nail pitting / onycholysis

    Pinprick pits, ridging or lifting of the nail plate — closely linked to DIP joint disease.

  • Spondylitis

    Inflammatory back pain, stiffness and reduced spinal mobility — sacroiliitis on imaging in a subset of patients.

  • Uveitis

    Painful red eye with blurred vision — needs same-day ophthalmology assessment.

  • Psoriasis flare

    Plaques on scalp, elbows, knees, umbilicus and natal cleft — a flare may accompany joint activity.

  • Red flag

    Hot swollen joint with fever — rule out septic arthritis. Call 999 or attend A&E the same day.

Treatment

How psoriatic arthritis is treated in the UK.

A layered approach: NSAIDs and DMARDs first, then biologics, JAK inhibitors or apremilast if disease activity persists — guided by GRAPPA and EULAR.

  • NSAID (early)

    First-line for mild peripheral disease or enthesitis — while awaiting rheumatology review.

  • DMARD (methotrexate, sulfasalazine)

    Conventional synthetic DMARDs for peripheral arthritis — methotrexate is the most commonly used.

  • Biologic anti-TNF

    Adalimumab and etanercept — highly effective for joints, skin, enthesitis and dactylitis.

  • IL-17 inhibitor

    Secukinumab and ixekizumab — targeted therapy for joint and skin disease when anti-TNF is not suitable.

  • IL-23 inhibitor

    Guselkumab and risankizumab — effective for skin and joint disease, with favourable safety profile.

  • JAK inhibitor

    Upadacitinib — oral targeted therapy for active PsA when biologics are inadequate or not tolerated.

  • PDE4 inhibitor

    Apremilast — oral option for mild-to-moderate disease, particularly where biologics are contraindicated.

  • Local injections / physio

    Steroid injections for isolated joints or entheses, plus tailored physiotherapy to preserve function.

What this guide is based on

The sources behind every claim on this page.

UK national guidance and international specialist society standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your GP or rheumatology team knows your history and can tell you which parts apply to you. If in doubt, get seen.

  • NICE. Psoriatic arthritis: management (NG196).

  • GRAPPA. Treatment recommendations for psoriatic arthritis.

  • EULAR. 2023 recommendations for the management of psoriatic arthritis with pharmacological therapies.

  • Psoriasis Association. Patient information and support.

Red flags

When psoriatic arthritis becomes an emergency.

PsA is usually a slow, chronic disease — but these situations need same-day medical attention.

  • Septic joint

    Fever with a hot, swollen, exquisitely tender joint — call 999 or attend A&E the same day.

  • Arthritis mutilans

    Rapidly progressive destructive small-joint disease with telescoping digits — needs urgent aggressive treatment.

  • Post-biologic infection

    Fever, night sweats or new cough on a biologic — screen for TB and opportunistic infection; contact your team.

  • Uveitis

    Painful red eye with blurred vision — needs same-day ophthalmology review to protect sight.

  • Cardiovascular event

    Chest pain or sudden breathlessness — PsA raises cardiovascular risk; do not delay assessment.

  • Pregnancy planning

    Methotrexate must be stopped well before conception — plan biologic choice with your team.

  • Neonatal / paediatric PsA

    Persistent joint swelling in a child with a family history of psoriasis — refer to paediatric rheumatology.

  • Progressive DIP joint destruction

    Rapid deformity of distal finger joints — urgent escalation of therapy to prevent damage.

  • Aortic involvement

    Chest pain, new murmur or breathlessness — rare but recognised aortitis and valve disease need cardiology review.

Living with it

A long-term condition, but a very manageable one.

Four things that make the biggest difference day to day — movement, a flare plan, nutrition, and regular reviews.

A quiet reminder

Consistency beats intensity, every time.

Small, steady changes — kept up for months — do more than a heroic week that does not last.

  1. 01 Movement

    Exercise is medicine

    Regular tailored activity reduces enthesitis, protects joints and improves fatigue.

  2. 02 Flares

    Have a plan

    Know what steps you take when a flare starts — and when to contact your team.

  3. 03 Nutrition

    No magic diet

    A Mediterranean-style diet, weight loss and oily fish help; smoking cessation reduces disease activity.

  4. 04 Reviews

    Regular reviews matter

    Joint counts, skin scores and treat-to-target reviews drive remission and long-term outcomes.

Frequently asked

Everything we get asked about psoriatic arthritis.

Quick answers on diagnosis, dactylitis, biologics, GRAPPA and joint-plus-skin care.

  • What is psoriatic arthritis?

    Psoriatic arthritis is an inflammatory arthritis that occurs in people with psoriasis or psoriatic nail disease. It affects joints, entheses (where tendons attach to bone), the spine and, in some patients, the eyes — and often overlaps with skin disease activity.

  • How is psoriatic arthritis diagnosed?

    By pattern (peripheral arthritis, dactylitis, enthesitis, nail changes, spondylitis) in the context of psoriasis, supported by blood tests (CRP, RF, anti-CCP), hand and foot X-rays, and musculoskeletal ultrasound or MRI when needed.

  • What is dactylitis?

    Dactylitis — the "sausage digit" — is uniform swelling of a whole finger or toe caused by combined joint and tendon-sheath inflammation. It is a hallmark of PsA and a marker of more severe disease.

  • What are biologics and how do they help?

    Biologics are injected or infused antibodies that target specific parts of the immune system — anti-TNF (adalimumab, etanercept), IL-17 (secukinumab, ixekizumab) and IL-23 (guselkumab, risankizumab) inhibitors have transformed PsA outcomes for both joints and skin.

  • What is GRAPPA?

    GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) is an international body that produces evidence-based treatment recommendations for psoriatic arthritis — used worldwide alongside NICE and EULAR guidance.

  • Does treating psoriasis help the arthritis?

    Yes — many modern biologics (IL-17 and IL-23 inhibitors especially) treat both skin and joint disease. Effective control of psoriasis often improves arthritis, and vice versa, so coordinated dermatology and rheumatology care matters.

Related content

Keep reading.

WhatsApp Call us
Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

Confidential. We respond within one working day.